SAI MedPartners
Overview
Global life sciences strategy consultancy providing competitive intelligence, market research, forecasting, and path-to-market strategy for pharmaceutical, biotech, and medical device clients, with on-the-ground research capabilities across the Americas, Europe, India, and Asia.
Notable
Northlane Capital Partners acquired SAI in June 2022; subsequent acquisitions of IDEA Pharma, Fulcrum Research Group, and PharmaForce expanded its commercialization and pathways-to-market expertise.
Key services
- competitive intelligence
- conference coverage and war gaming
- market research
- forecasting
- path-to-market and launch strategy
Subcategories
Verified Reviews
No verified reviews yet — are you a customer of SAI MedPartners? Share your experience in a short, confidential interview.
Share your experience